Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID (RAG1-SCID)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04797260 |
|
Recruitment Status :
Recruiting
First Posted : March 15, 2021
Last Update Posted : April 18, 2024
|
Sponsor:
Leiden University Medical Center
Collaborators:
ZonMw: The Netherlands Organisation for Health Research and Development
Horizon 2020 - European Commission
Information provided by (Responsible Party):
alankester, Leiden University Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 31, 2029 |
| Estimated Study Completion Date : | December 31, 2029 |